title: Do we really need alternatives to polymorphonuclear cells counting in ascitic fluid?
authors.forename: Oliviero
authors.initials: O
authors.lastname: Riggio
authors.forename: Chiara
authors.initials: C
authors.lastname: Marzano
authors.forename: Stefania
authors.initials: S
authors.lastname: Angeloni
authors.forename: Manuela
authors.initials: M
authors.lastname: Merli
mesh_terms: D001202:Ascitic Fluid / Q000378:metabolism / Q000473:pathology*; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000473:pathology; D017048:Health Care Costs; D006801:Humans; D007781:Lactoferrin / Q000378:metabolism; D007958:Leukocyte Count; D008403:Mass Screening / Q000191:economics / Q000379:methods; D009504:Neutrophils / Q000473:pathology*; D010538:Peritonitis / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology; D012680:Sensitivity and Specificity
chemical_list: D007781:Lactoferrin